Wenjie Tan to Viral Vaccines
This is a "connection" page, showing publications Wenjie Tan has written about Viral Vaccines.
Connection Strength
1.288
-
Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates. Vaccine. 2019 04 03; 37(15):2122-2130.
Score: 0.169
-
Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect. 2018 Apr 04; 7(1):60.
Score: 0.159
-
Dr. Chi-Ming Chu: Respected founder of molecular virology and pioneer of biologicals in China. Protein Cell. 2017 09; 8(9):629-633.
Score: 0.153
-
[Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice]. Bing Du Xue Bao. 2016 Jan; 32(1):77-81.
Score: 0.136
-
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge. EBioMedicine. 2015 Oct; 2(10):1438-46.
Score: 0.132
-
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology. 2015 Aug; 145(4):476-84.
Score: 0.129
-
Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen. PLoS One. 2014; 9(11):e112602.
Score: 0.126
-
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity. Signal Transduct Target Ther. 2021 05 31; 6(1):213.
Score: 0.049
-
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
Score: 0.046
-
Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus. Virol Sin. 2018 Oct; 33(5):453-455.
Score: 0.041
-
A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg Microbes Infect. 2017 May 24; 6(5):e37.
Score: 0.037
-
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC. J Immunol. 2017 01 15; 198(2):873-882.
Score: 0.036
-
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. Antiviral Res. 2017 01; 137:82-92.
Score: 0.036
-
The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. Viral Immunol. 2014 Dec; 27(10):543-50.
Score: 0.032
-
SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice. Viral Immunol. 2009 Feb; 22(1):57-66.
Score: 0.005